The public meeting, “Modernizing Oncology Endpoints: Pathways for Evidence and Policy,” hosted by Friends of Cancer Research, is scheduled for Thursday, February 5, 2026, from 9:30 AM to 2:00 PM ET.

This event, which will be held at The Ritz-Carlton in Washington, DC, and streamed virtually, is focused on reviewing the current landscape and application of evolving early endpoints in oncology. The meeting will explore how novel measurements, such as ctDNA and AI-based tumor assessments (including insights from Friends’ ai.RECIST and ctMoniTR Projects), can improve clinical trial efficiency, inform regulatory decision-making, and advance future policy frameworks.

Register.